A natural compound derived from gut-friendly bacteria significantly slows the progression of vitiligo and may restore pigmentation, reports a new pre-clinical study in mice.
Results in vitiligo came from the TRuE-V1 and TRuE-V2 studies, which showed that around 30% of patients treated with ruxolitinib cream twice daily achieved 75% or more improvement from baseline in ...
A few days ago, millions around the world cheered when the US Food and Drug Administration (FDA) approved a treatment for vitiligo - a topical cream that can restore pigment with unprecedented ...
If you’re looking for a cannabidiol (CBD) product to soothe your aches and pains, a topical CBD — such as a CBD cream — may be particularly useful. But how can you tell which CBD creams are ...
In 2022, the FDA approved the first re-pigmentation therapy for vitiligo: Opzelura (ruxolitinib) cream. Clinical trials found that only 30% of patients using the cream regained 75% or more skin ...
Individuals with vitiligo showed similar cancer incidence rates per 100,000 person-years as matched controls. Reduced risks for melanoma, lung and bladder cancers were found. Individuals with ...
"The method is safe, painless, and incurs no additional treatment costs. Studies indicate that it is suitable for use in children and pregnant women as well," said Prof Swastika Suvirya, head of ...
Incyte is preparing to take an oral JAK inhibitor into phase 3 trials for the skin depigmentation disease vitiligo, after reporting mid-stage data showing efficacy in patients with facial and full ...